Found 30 matching trials
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery PHASE3 This is a prospective, multicenter, randomized, open-label, phase III non-i...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer PHASE3 POLAR is a phase III clinical trial, which will test the safety and efficac...
Show More Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Learn More & Join Trial
CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer PHASE3 The investigators designed a phase III clinical trial involving hormone rec...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) PHASE3 This is a Phase III, global, randomized, open-label, multicenter, study eva...
Show More Status
Active Not Recruiting
Location
Southern Cancer Center
Learn More & Join Trial
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence PHASE3 The primary goal of this study is to evaluate the effectiveness of elacestr...
Show More Location
Southern Cancer Center, PC
Learn More & Join Trial
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery PHASE2 Doctors leading this study would like to learn about providing cancer treat...
Show More Location
Lagos State University Teaching Hospital
Learn More & Join Trial
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) PHASE3 This is a Phase III open-label study to assess if camizestrant improves out...
Show More Status
Active Not Recruiting
Learn More & Join Trial
STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) PHASE3 The purpose of this study is to determine whether starting anastrozole prio...
Show More Location
The Canberra Hospital
Learn More & Join Trial
Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4) PHASE3 RATIONALE: Estrogen can cause the growth of breast cancer cells. Letrozole ...
Show More Status
Active Not Recruiting
Location
Istituto Nazionale per la Ricerca sul Cancro
Learn More & Join Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer PHASE3 This randomized phase III clinical trial studies how well tamoxifen citrate...
Show More Status
Active Not Recruiting
Location
Northeast Alabama Regional Medical Center
Learn More & Join Trial